Expansion and cytotoxicity of mucosal CAR+ T cells in enterocolitis associated with BCMA CAR-T cell therapy
Year: 2026
Type: article
Abstract: Ciltacabtagene autoleucel (cilta-cel) is a B cell maturation-antigen-targeting chimeric antigen receptor (CAR) T cell product approved for relapsed/refractory multiple myeloma treatment. Previously reported cases of post-cilta-cel immune effector cell enterocolitis (IEC-EC) have been described as a severe diarrhea associated with clonal CAR T cell populations. Here we report nine cases of cilta-cel-associated IEC-EC with CAR T cell-positive (CAR + ) infiltration in 158 cilta-cel-treated patients at MD Anderson Cancer Center (incidence of 5.1% at a 6-month landmark and 5.7% globally). Cilta-cel infiltration was the primary cause of IEC-EC, and all cases demonstrated monoclonal or oligoclonal T cell populations as measured by vector integration analysis, flow cytometry and T cell receptor sequencing. Patients with IEC-EC had 100-fold more CAR T cell persistence in the peripheral blood than patients without IEC-EC. RNA sequencing analysis revealed increased cytotoxic and inflammatory programs associated with the CAR + infiltrates relative to controls. Clonal vector integration occurred in introns of highly expressed genes without evidence of vector-mediated mutagenesis. Candidate driver mutations were sparse and heterogeneous, distinguishing IEC-EC from peripheral T cell lymphoma following CAR T cell therapy. In sum, we find that IEC-EC pathology represents a distinct, duodenum-predominant, clonal lymphoproliferative disorder characterized by the infiltration of clonal CAR + cytotoxic T cells into the gastrointestinal tract.
Source: Nature Medicine
Authors: Tania P. Sainz, Sharlene Dong, Aniruddha Mundhada, Wei Wang, Hector Garcia Pleitez, Carla Villela, Jared Henderson, Amy A. Ayers, Karmila Murphy, Francisco Cortina, Bita Sahaf, Snehit Prabhu, Partow Kebriaei, Wei-Lien Wang, Christopher D. Pacheco, Xuehong Gui, Christopher R. Flowers, Sattva S. Neelapu, Paolo Strati, Mahmoud R. Gaballa, Oren Pasvolsky, Robert Orlowski, Keyur Patel, Surbhi Sidana, Crystal Mackall, David B. Miklos, Yinghong Wang, David M. Richards, Sairah Ahmed, Michael R. Green, Lekha Mikkilineni, Sa A. Wang, Ziyi Li, Swami P. Iyer, Krina K. Patel, Francisco Vega, Mark P. Hamilton
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $12,690
OpenAlex ID: W7236567489
